PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
Investigators assessed PSA response to treatment at various time points for their relative abilities to predict disease progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC ...
John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...
Multiparametric MRI detects more local recurrences after prostatectomy than prostate-specific membrane antigen PET-CT, with the two showing only moderate agreement.
Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...
Prostate cancer was found in 23% of men whose initially abnormal PSA levels fell to below 4 ng/mL. Men whose PSA levels rise above 4 ng/mL—a commonly used threshold for prostate biopsy—but then ...
The Independent on MSN
I was diagnosed with prostate cancer – this is what men need to know
I was diagnosed with prostate cancer – this is what all men need to know - FIRST PERSON: A routine check led to months of ...
February 10, 2023 – Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with ...
For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...
What Are Biomarkers? A Guide to Understanding the Health Indicators Key Takeaways: Biomarkers — aka biological markers — are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback